• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子设备检测到的长时间心房高频率发作在有和没有心房颤动病史的患者之间的差异预后影响。

The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation.

作者信息

Ishiguchi Hironori, Yoshiga Yasuhiro, Shimizu Akihiko, Ueyama Takeshi, Ono Makoto, Fukuda Masakazu, Kato Takayoshi, Fujii Shohei, Hisaoka Masahiro, Uchida Tomoyuki, Omuro Takuya, Okamura Takayuki, Kobayashi Shigeki, Yano Masafumi

机构信息

Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, Ube 755-8508, Japan.

Department of Cardiology, Ube-Kohsan Central Hospital, Ube 755-0151, Japan.

出版信息

J Clin Med. 2022 Mar 21;11(6):1732. doi: 10.3390/jcm11061732.

DOI:10.3390/jcm11061732
PMID:35330056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954400/
Abstract

Long-duration atrial high-rate episodes (AHREs) monitored using cardiac implantable electronic devices (CIEDs) can predict long-term major adverse cardiovascular events (MACEs). This study aimed to compare the impact of long-duration AHRE on MACE development between patients with and without a history of atrial fibrillation (AF). This single-center observational study included 132 CIED-implanted patients with AHREs detected via remote monitoring. The population was dichotomized into groups: with (n = 69) and without (n = 63) AF. In each group, cumulative incidences of MACEs comprising all-cause deaths, heart failure hospitalizations, strokes, and acute coronary syndromes were compared between patients with AHRE durations of ≥24 h and <24 h. Multivariate analysis was performed to identify predictors of MACEs among patients without AF. MACE incidence was significantly higher in patients with AHRE ≥24 h than in those with <24 h in the group without AF (92% vs. 30%, p = 0.005). MACE incidence did not significantly differ between AHRE ≥24 h and <24 h in the group with AF (54% vs. 26%, p = 0.44). After a multivariate adjustment, AHRE duration of ≥24 h emerged as the only independent predictor of MACEs among patients without AF (p = 0.03). In conclusion, a long-duration AHRE was prognostic in patients without a history of AF but not in patients with a history of AHREs.

摘要

使用心脏植入式电子设备(CIED)监测到的长时间心房高频率发作(AHRE)可预测长期主要不良心血管事件(MACE)。本研究旨在比较有和没有心房颤动(AF)病史的患者中,长时间AHRE对MACE发生的影响。这项单中心观察性研究纳入了132例通过远程监测检测到有AHRE的CIED植入患者。将研究人群分为两组:有AF组(n = 69)和无AF组(n = 63)。在每组中,比较了AHRE持续时间≥24小时和<24小时的患者中,包括全因死亡、心力衰竭住院、中风和急性冠状动脉综合征在内的MACE累积发生率。对无AF患者进行多变量分析以确定MACE的预测因素。在无AF组中,AHRE≥24小时的患者MACE发生率显著高于AHRE<24小时的患者(92%对30%,p = 0.005)。在有AF组中,AHRE≥24小时和<24小时的患者MACE发生率无显著差异(54%对26%,p = 0.44)。经过多变量调整后,AHRE持续时间≥24小时成为无AF患者中MACE的唯一独立预测因素(p = 0.03)。总之,长时间AHRE对无AF病史的患者具有预后意义,但对有AF病史的患者则不然。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/ebfd02d7c97d/jcm-11-01732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/b42331ab8719/jcm-11-01732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/c2ebeace532f/jcm-11-01732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/72ec17347e62/jcm-11-01732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/ebfd02d7c97d/jcm-11-01732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/b42331ab8719/jcm-11-01732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/c2ebeace532f/jcm-11-01732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/72ec17347e62/jcm-11-01732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a703/8954400/ebfd02d7c97d/jcm-11-01732-g004.jpg

相似文献

1
The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation.心脏植入式电子设备检测到的长时间心房高频率发作在有和没有心房颤动病史的患者之间的差异预后影响。
J Clin Med. 2022 Mar 21;11(6):1732. doi: 10.3390/jcm11061732.
2
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation.心脏植入式电子设备检测到的心房高频率发作:发作的动态变化及房颤事件的预测因素
Biology (Basel). 2022 Mar 15;11(3):443. doi: 10.3390/biology11030443.
3
Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.植入式设备检测到的心房高频事件负担与未来心力衰竭事件相关 - 植入式心脏电子设备患者无症状心房颤动的临床意义。
Circ J. 2019 Mar 25;83(4):736-742. doi: 10.1253/circj.CJ-18-1130. Epub 2019 Feb 26.
4
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.心房高频事件与植入式心脏电子设备患者主要不良心血管事件风险的关系。
Clin Res Cardiol. 2020 Jan;109(1):96-102. doi: 10.1007/s00392-019-01493-z. Epub 2019 May 29.
5
Does the CHADS-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices.CHADS-VASc 评分能否可靠地预测心房颤动?来自心脏植入式电子设备每日远程监测数据的全国性数据库分析。
Heart Rhythm. 2018 Jul;15(7):971-979. doi: 10.1016/j.hrthm.2018.02.023. Epub 2018 Mar 1.
6
Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices.单核细胞与高密度脂蛋白比值在预测心脏植入式电子设备检测到的心房高率发作中的作用。
North Clin Istanb. 2018 Apr 12;5(2):96-101. doi: 10.14744/nci.2017.35761. eCollection 2018.
7
Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.心脏再同步治疗患者中房性高率发作的早期检测可预测心房颤动和血栓栓塞事件。
Heart Rhythm. 2015 Dec;12(12):2368-75. doi: 10.1016/j.hrthm.2015.07.007. Epub 2015 Jul 8.
8
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices.植入式除颤器和再同步装置检测到的心房高心率事件患者的特征。
Europace. 2022 Mar 2;24(3):375-383. doi: 10.1093/europace/euab186.
9
Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.心脏植入式电子设备患者中与心房高频率发作相关的无症状性缺血性脑损伤。
Europace. 2015 Mar;17(3):364-9. doi: 10.1093/europace/euu267. Epub 2014 Oct 21.
10
P-wave and interatrial block: New predictor for atrial high rate episodes in patients with cardiac implantable electronic devices.P波与房间阻滞:心脏植入式电子设备患者房性快速心律失常发作的新预测指标。
Pacing Clin Electrophysiol. 2018 Mar;41(3):223-228. doi: 10.1111/pace.13268. Epub 2018 Feb 6.

引用本文的文献

1
Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?左西孟旦对窦性心律或心房颤动的晚期射血分数降低的心力衰竭(HFrEF)患者的治疗效果有差异吗?
Front Cardiovasc Med. 2023 Feb 23;10:1084300. doi: 10.3389/fcvm.2023.1084300. eCollection 2023.

本文引用的文献

1
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis.器械检测到的心房高心率事件与卒中/血栓栓塞和心房颤动发生率的风险:系统评价和荟萃分析。
Eur J Intern Med. 2021 Oct;92:100-106. doi: 10.1016/j.ejim.2021.05.038. Epub 2021 Jun 19.
2
Association Between Atrial High-Rate Episodes and Ischemic/Major Bleeding Events in Patients With a Cardiac Implantable Electronic Device - A 10-Year, Single-Center Historical Cohort Study.心脏植入式电子设备患者的心房高频事件与缺血/大出血事件的相关性——一项 10 年单中心历史队列研究。
Circ J. 2021 Jul 21;85(8):1329-1337. doi: 10.1253/circj.CJ-20-1269. Epub 2021 Apr 16.
3
Atrial high‑rate episodes and risk of major adverse cardiovascular events in patients with dual chamber permanent pacemakers: a retrospective study.
双腔永久起搏器患者的心房高频事件与主要不良心血管事件风险:一项回顾性研究。
Sci Rep. 2021 Mar 11;11(1):5753. doi: 10.1038/s41598-021-85301-7.
4
Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.器械检测到的无症状性心房颤动与心脏再同步治疗除颤器患者心力衰竭之间的关系。
Clin Cardiol. 2020 Dec;43(12):1517-1523. doi: 10.1002/clc.23471. Epub 2020 Sep 29.
5
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
6
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
7
Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study.45 年来与心房颤动相关的超额死亡率趋势(弗雷明汉心脏研究):基于社区的队列研究。
BMJ. 2020 Aug 11;370:m2724. doi: 10.1136/bmj.m2724.
8
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.心房高频事件与植入式心脏电子设备患者主要不良心血管事件风险的关系。
Clin Res Cardiol. 2020 Jan;109(1):96-102. doi: 10.1007/s00392-019-01493-z. Epub 2019 May 29.
9
Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.植入式设备检测到的心房高频事件负担与未来心力衰竭事件相关 - 植入式心脏电子设备患者无症状心房颤动的临床意义。
Circ J. 2019 Mar 25;83(4):736-742. doi: 10.1253/circj.CJ-18-1130. Epub 2019 Feb 26.
10
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.